MarketCap
Facebook
X
Telegram
CareDx, Inc EV/EBITDA Ratio | CDNA
Annual EV/EBITDA Ratio CareDx, Inc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -65.8 | 17.9 | -3.41 | -12.3 | -102 | -214 | -51.6 | -86.6 | -11.9 | -2.19 | -3.91 | 30.7 | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 30.7 | -214 | -42.1 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Chembio Diagnostics
CEMI
|
-1.86 | - | 0.22 % | $ 16.8 M |  USA |
 |
DermTech
DMTK
|
-0.68 | - | -11.32 % | $ 2.94 M | USA |
 |
Surmodics
SRDX
|
189 | - | - | $ 608 M | USA |
 |
Invitae Corporation
NVTA
|
44.6 | - | - | $ 21.2 M | USA |
 |
Syneos Health
SYNH
|
7.06 | - | - | $ 4.46 B | USA |
 |
Motus GI Holdings
MOTS
|
-0.0496 | - | -34.28 % | $ 263 K |  Israel |
 |
Heska Corporation
HSKA
|
-134 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-0.156 | - | -20.0 % | $ 1.06 M | USA |
 |
Renalytix AI plc
RNLX
|
-1.16 | - | 5.66 % | $ 22.7 M |  Britain |
 |
Psychemedics Corporation
PMD
|
-2.23 | - | -1.84 % | $ 15.3 M | USA |
 |
Meridian Bioscience
VIVO
|
18.4 | - | - | $ 1.49 B | USA |
 |
DexCom
DXCM
|
24.2 | $ 79.92 | -1.42 % | $ 31.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
10.8 | $ 258.38 | -0.5 % | $ 28.7 B | USA |
 |
Castle Biosciences
CSTL
|
-227 | $ 34.41 | 0.07 % | $ 997 M | USA |
 |
IDEXX Laboratories
IDXX
|
35 | $ 696.77 | -1.4 % | $ 56 B | USA |
 |
Illumina
ILMN
|
22.1 | $ 214.84 | -2.69 % | $ 33.3 B | USA |
 |
Anixa Biosciences
ANIX
|
-0.0846 | $ 3.05 | -3.48 % | $ 99 K | USA |
 |
Biodesix
BDSX
|
-8.27 | $ 10.04 | -2.95 % | $ 75.8 M | USA |
 |
BioNano Genomics
BNGO
|
-1.43 | $ 1.25 | 7.66 % | $ 6.81 M | USA |
 |
Bioventus
BVS
|
10 | $ 11.18 | 1.5 % | $ 745 M | USA |
 |
Fulgent Genetics
FLGT
|
-8.71 | $ 25.83 | -1.22 % | $ 795 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | Britain |
 |
Biomerica
BMRA
|
-1.7 | $ 1.48 | -4.52 % | $ 4.31 M | USA |
 |
Interpace Biosciences
IDXG
|
3.62 | $ 7.0 | -13.43 % | $ 31 M | USA |
 |
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | USA |
 |
ICON Public Limited Company
ICLR
|
20 | $ 204.62 | -1.43 % | $ 16 B |  Irlanda |
 |
Co-Diagnostics
CODX
|
0.0391 | $ 0.29 | -9.5 % | $ 386 K | USA |
 |
Burning Rock Biotech Limited
BNR
|
5.84 | $ 13.19 | 6.46 % | $ 135 M |  China |
 |
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | USA |
 |
DarioHealth Corp.
DRIO
|
-0.303 | $ 2.37 | 15.05 % | $ 9.44 M | Israel |
 |
Myriad Genetics
MYGN
|
-1.79 | $ 5.66 | -1.39 % | $ 524 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-0.785 | $ 4.78 | -1.24 % | $ 3.76 M | USA |
 |
QIAGEN N.V.
QGEN
|
-1.27 | $ 50.52 | -0.07 % | $ 11 B |  Niderland |
 |
NeoGenomics
NEO
|
-23.2 | $ 16.97 | -3.58 % | $ 2.17 B | USA |
 |
OPKO Health
OPK
|
-51.8 | $ 1.71 | 0.58 % | $ 1.28 B | USA |
 |
Pacific Biosciences of California
PACB
|
-2.24 | $ 2.22 | -5.93 % | $ 666 M | USA |
 |
Neogen Corporation
NEOG
|
37.8 | $ 11.67 | -3.44 % | $ 2.54 B | USA |
 |
Precipio
PRPO
|
988 | $ 23.56 | 6.13 % | $ 37.8 M | USA |
 |
Personalis
PSNL
|
-4.87 | $ 15.9 | -0.31 % | $ 1.42 B | USA |
 |
Sotera Health Company
SHC
|
74.5 | $ 16.25 | -1.16 % | $ 4.61 B | USA |
 |
Quidel Corporation
QDEL
|
9.16 | $ 11.56 | -4.43 % | $ 487 M | USA |
|
Centogene N.V.
CNTG
|
0.283 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Trinity Biotech plc
TRIB
|
-15.5 | $ 5.88 | 10.08 % | $ 2.11 B | Irlanda |
 |
Global Cord Blood Corporation
CO
|
-4.15 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-0.932 | - | 0.12 % | $ 80.1 M | China |
 |
Aspira Women's Health
AWH
|
-1.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Check-Cap Ltd.
CHEK
|
0.000843 | - | - | $ 9.42 M | Israel |
 |
Exact Sciences Corporation
EXAS
|
-270 | - | - | $ 19.8 B | USA |